Neumora Therapeutics
NMRA
#7984
Rank
โ‚น19.71 B
Marketcap
โ‚น121.71
Share price
1.45%
Change (1 day)
-90.08%
Change (1 year)

Neumora Therapeutics (NMRA) - Cash on Hand

Cash on Hand as of December 2024 : โ‚น26.74 Billion

According to Neumora Therapeutics's latest financial reports the company has โ‚น26.74 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neumora Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น26.38 B-30.18%
2023-12-31โ‚น37.79 B22.81%
2022-12-31โ‚น30.77 B1.03%
2021-12-31โ‚น30.46 B116.96%
2020-12-31โ‚น14.04 B
2019-12-31N/A